Søgeresultater - Nilofer S. Azad
- Showing 1 - 20 results of 52
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Single-Center Phase II Trial of Transarterial Chemoembolization With Drug-Eluting Beads for Patients With Unresectable Hepatocellular Carcinoma af Diane K. Reyes, Josephina A. Vossen, Ihab R. Kamel, Nilofer S. Azad, T. Wahlin, Michael Torbenson, Michael A. Choti, Jean-François H. Geschwind
Udgivet 2009Artigo -
10
Tumor Mutational Burden, Toxicity, and Response of Immune Checkpoint Inhibitors Targeting PD(L)1, CTLA-4, and Combination: A Meta-regression Analysis af Arsen Osipov, Su Jin Lim, Aleksandra Popović, Nilofer S. Azad, Daniel A. Laheru, Lei Zheng, Elizabeth M. Jaffee, Hao Wang, Mark Yarchoan
Udgivet 2020Revisão -
11
A randomized pilot trial of a telephone‐based couples intervention for physical intimacy and sexual concerns in colorectal cancer af Jennifer Barsky Reese, Laura S. Porter, Katelyn R. Regan, Francis J. Keefe, Nilofer S. Azad, Luis A. Díaz, Joseph M. Herman, Jennifer A. Haythornthwaite
Udgivet 2014Artigo -
12
Combined Inhibition of Cyclin-Dependent Kinases (Dinaciclib) and AKT (MK-2206) Blocks Pancreatic Tumor Growth and Metastases in Patient-Derived Xenograft Models af Chaoxin Hu, Tikva Dadon, Venugopal Chenna, Shinichi Yabuuchi, Rajat Bannerji, Robert Booher, Peter R. Strack, Nilofer S. Azad, Barry D. Nelkin, Anirban Maitra
Udgivet 2015Artigo -
13
-
14
-
15
Gastrointestinal ostomies and sexual outcomes: a comparison of colorectal cancer patients by ostomy status af Jennifer Barsky Reese, Patrick H. Finan, Jennifer A. Haythornthwaite, Maura Kadan, Katelyn R. Regan, Joseph M. Herman, J. Efron, Luis A. Díaz, Nilofer S. Azad
Udgivet 2013Artigo -
16
Performance characteristics of next-generation sequencing in clinical mutation detection of colorectal cancers af Lisa Haley, Li‐Hui Tseng, Gang Zheng, Jonathan C. Dudley, Derek A. Anderson, Nilofer S. Azad, Christopher D. Gocke, James R. Eshleman, Ming‐Tseh Lin
Udgivet 2015Artigo -
17
Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases af Georgios Karagkounis, Michael Torbenson, Hubert Darius Daniel, Nilofer S. Azad, Luis A. Díaz, Ross C. Donehower, Kenzo Hirose, Nita Ahuja, Timothy M. Pawlik, Michael A. Choti
Udgivet 2013Artigo -
18
The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma af Rachna T. Shroff, Mark Yarchoan, Ashley O’Connor, Denise Gallagher, Marianna Zahurak, Gary L. Rosner, Chimela Ohaji, Susan Sartorius‐Mergenthaler, Vivek Subbiah, Ralph Zinner, Nilofer S. Azad
Udgivet 2017Artigo -
19
Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours af Devalingam Mahalingam, George Wilding, Samuel R. Denmeade, J. Sarantopoulas, David Cosgrove, Jeremy Cetnar, Nilofer S. Azad, Justine Y. Bruce, Michael R. Kurman, Victoria Allgood, Michael A. Carducci
Udgivet 2016Artigo -
20
Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017 af Milind Javle, Sunyoung Lee, Nilofer S. Azad, Mitesh J. Borad, Robin Kate Kelley, Smitha Sivaraman, Anna Teschemaker, Ishveen Chopra, Nora A. Janjan, Shreekant Parasuraman, Tanios Bekaii‐Saab
Udgivet 2022Artigo
Søgeredskaber:
Relaterede emner
Medicine
Internal medicine
Cancer
Oncology
Cancer research
Biology
Colorectal cancer
Gene
Chemotherapy
Biochemistry
Genetics
Immunotherapy
Immunology
Gastroenterology
Immune system
Chemistry
Pharmacology
Mutation
Biomarker
KRAS
Pancreatic cancer
Clinical trial
Hepatocellular carcinoma
Immune checkpoint
Pembrolizumab
Tumor microenvironment
Adverse effect
Disease
Leukopenia
Neutropenia